The CSIR DG said the transmissibility of the new strain N501Y is a "bit higher" but this does not mean it is more lethal and more people are going to die due to it.
Cadila, Biocon developing rapid antibody testing kits; Eris, Mylan, Gland importing. There are two kinds of testing for the novel coronavirus - the real-time polymerase chain reaction test kit that uses throat or nasal swabs and provides results in a few hours, and the other is antibody-based rapid testing kit that use blood samples and provides results in a few minutes.
The rapid surge in cases during Delhi's fourth COVID-19 wave was mainly driven by the Delta variant, which likely has immune-evasion properties and counted for 60 per cent of the cases in April, according to a new study.
Some experts opine that green crackers are yet not practical and question government's move to promote them.
Without naming the entity, he said some players are at a pre-clinical stage and may reach the clinical stage by October. Responding to a question on absence of a vaccine currently and the prospects in the next few months as the lockdown eases, VijayRaghvan emphasised on aggressive rapid testing and tracking.
The judge also said that even an accidental physical contact, though unwelcome, would not amount to sexual harassment.
'The deaths of the children in the Gambia would batter India's reputation as the developing world's pharmacy.'
Britain has revoked visas issued to two prominent members of organisations with right-wing leanings from Kerala after the Indian community in the UK complained against their visit.
'The RSS has opposed the introduction of GM Mustard tooth and nail, but PM Modi does not give a hoot for what they think.'
The non-viability of green crackers may pave the way for e-crackers.
The changeover to green crackers after extensive experiments marks a revival of the industry which has over 1,000 manufacturing units around Sivakasi and used to clock an annual turnover of over Rs 6,000 crore.
Air Chief Marshal B S Dhanoa calling the FOC a 'major milestone'.
'Well begun is half done, today there are more hits than misses by the Modi government in its support towards science in India,' says Pallava Bagla.
Joint Secretary in the Health Ministry Lav Agarwal claimed that India has been doing better than many other countries on the outcome ratio, which is the number of recoveries from coronavirus infection versus the number of deaths.
Science in India has developed a great deal since C V Raman, particularly after the country gained Independence but we are yet to win a Nobel prize in physics, chemistry or medicine. Is it a reflection on the quality of Indian science? Or it has to do with the politics of Nobel prizes, as is often believed, asks Dinesh C Sharma.
A rise in the number of daily COVID-19 cases and mortality has been observed in Assam, West Bengal, Odisha, Bihar and Jharkhand, indicating the pandemic is moving eastwards, the Union health ministry said.
The novel mRNA vaccine candidate, HGCO19, is supported with seed grant under the Ind-CEPI mission of the Department of Biotechnology. The mRNA vaccines do not use the conventional model to produce immune response. Instead, they carry molecular instructions to make the protein in the body through a synthetic RNA of the virus.
The expert panel, set up by the home ministry to find an alternative to pellet guns, is believed to have zeroed in on 'PAVA shells', a chilli-based ammunition, which is less lethal and immobilises the target.
PAVA shells'are a chilli-based ammunition, which is less lethal and immobilises the target temporarily.
'Given that the globally most prevalent clade of SARS-CoV-2 is also predominant in India, any vaccine or drug that gets developed in the world should also prove effective in India'
Environment Minister Harsh Vardhan on Tuesday instructed the states in the National Capital Region to take all possible measures to prevent any spike in air pollution levels during the upcoming Under-17 FIFA World Cup in Delhi to save India the blushes.
'In case of shortage of other raw material, like filters and bags, one can try to develop another vendor. However, for chemicals as critical as adjuvants, this is not possible'
ICMR says it is following all globally accepted norms to fast-track vaccine and wants to 'cut red tape'.
Four veterans of the Indian National Army, an all-women contingent of the 183-year-old Assam Rifles marching down Rajpath and an Indian Air Force aircraft flying using a mix of traditional and biofuel.
"We are committed to building a new India. We have to do this as early as possible," he said.
The 'Make in India' concept in the defence sector has the potential to help India meet 70 per cent of its defence needs in a few years.
Bharat Biotech recruited 13,000 participants for the Phase-3 clinical trial of Covaxin. This is one of the largest efficacy trials held in the country.
5 things you must know about this scientific trailblazer.
She is the first woman lawyer to enter the top judiciary directly.
The SC said, "You must tell us some way of preventing unemployment also. We cannot have people unemployed and hungry. There are areas where firecrackers can be used."
Over 5 million alumni from the Indian Institutes of Technology, Mumbai University and Institute of Chemical Technology, Mumbai, plan to raise Rs 21,000 crore to start the world's largest infection testing lab in Mumbai.
'Better hygiene practices could lower a person's immunity and make the person susceptible to auto-immune diseases.'
Ajai Shukla presents an action plan for Defence Minister Rajnath Singh to fix the systemic weaknesses in defence.
We have our own problems for sure and they are not trivial, but for now, our economy is in not too bad a shape, our politics is as personality-driven and authoritarian as that of most countries in the world. We must make the best of what we have and not be excessively unhappy looking at the grass on the other side of the septic tank which may not be greener after all!, observes Shreekant Sambrani.
'WHO has been under a lot of attack, so when they saw the Lancet study, they stopped the clinical trials of HCQ.' 'They should not have stopped the clinical trials.'
The Centre on Monday earmarked a separate Rs 2,217 crore for 42 urban centres to tackle air pollution and announced the much-awaited voluntary vehicle scrapping policy to phase out old and polluting vehicles, even as it shrunk the budgetary allocation for the environment ministry from the last fiscal by nearly eight percent. Union Finance Minister Nirmala Sitharaman, in her budget speech for 2021-22, announced a total of Rs 2869.93 crore for the ministry, Rs 230 crore less than the last fiscal. Officials said the outlay has been lesser this time as the economy is recovering from the COVID-19 pandemic.
Globally, Coca-Cola offers Fanta in various fruit-based formats. Apple, Strawberry, Pineapple and Creaming soda are a few of the 90 variants that are available in different markets, apart from orange.
Can we make high speed 4G Internet available at 10 cents per GB, and make all voice calls free of cost -- that too in a large and diverse country like India? Can we make high-quality but simple breast cancer screening available to every woman, that too at the extremely affordable cost of $1 per scan? Can we make a portable, high-tech ECG machine which can provide reports immediately and that too at the cost of 8 cents a test? Can we make an eye imaging device that is portable, non-invasive and costs 3 times less that conventional devices? Can we make a robust test for mosquito-borne dengue, which can detect the disease on day 1, and that too at the cost of $2 per test? Amazingly, says Dr R A Mashelkar, the eminent scientist, all this has been achieved in India, not only by using technological innovation but also non-technological innovation.
'We are moving away from the path of democracy and towards Hindu religious dictatorship,' scientist P M Bhargava, who announced his decision to return the Padma Bhushan, tells Syed Firdaus Ashraf/Rediff.com
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances